Nicox submits new drug application for AC-170 to U.S. FDA
Tuesday, April 19, 2016
Nicox SA Submits new drug application for AC-170 to U.S. FDA.
Approval of the AC-170 NDA prior to 1st December 2016 will trigger a milestone payment of $35 million in Nicox shares to ex-Aciex shareholders or $10 million in Nicox shares if approval of the NDA is received after this date.
Also commenced an additional clinical safety study on AC-170.
Source : reuters.com
